Exosomes are extracellular vesicles ranging from 30 to 150 nm in diameter that are released from various types of cells, including tumor cells. They can induce apoptosis, modulate the immune system, and function as biomarkers for diagnosis. In addition, as an important component of cell-to-cell communication, exosomes can regulate the tumor microenvironment and are involved in the development, progression, and metastasis processes of numerous cancers1,2.
Mega Series C in Switzerland
BackgroundAlentis is the only company developing potential treatments for solid cancers and fibrosis targeting Claudin-1 (CLDN1). The molecule is significantly involved in the tight junction between cells. Now the company closed a three digit million Seriec C round.
How to clean with bacteria
BackgroundFrom bacteria to cellulose fibers and lab grown paper. A greek project paves the way to save trees.
Gleamer raises €27m in Series B funding round
Latest NewsFrench AI-powered radiography diagnostics specialist Gleamer SAS has raises €27m in Series B round to expand its portfolio and accelerate its expansion.
Tumor Exosomes: A Messenger for Cancer Progression
Sponsored PublicationsExosomes are extracellular vesicles ranging from 30 to 150 nm in diameter that are released from various types of cells, including tumor cells. They can induce apoptosis, modulate the immune system, and function as biomarkers for diagnosis. In addition, as an important component of cell-to-cell communication, exosomes can regulate the tumor microenvironment and are involved in the development, progression, and metastasis processes of numerous cancers1,2.
Centogene and Lifera kick-off joint venture
Latest NewsMulti-omics diagnostics specialist Centogene NV has received €30m to form a joint venture with PIF-owned pharmaceutical company Lifera in Saudi-Arabia.
Cresset creates new Vice President role
AppointmentsUK-based CRO Cresset has expanded its senior leadership team with the appointment of Nick Foster as Vice President of their Discovery CRO business.
Astraveus SAS bags €16.5m in seed financing
Latest NewsFrench cell and gene therapy manufacturing specialist Astraveus SAS had raises €16.5m in seed money to advance its automated, microfluidic Cell and Gene Therapy manufacturing platform.
New BIOTECH insight newsletter out
Latest NewsBreaking news from biotechnology and the German stock market are in the focus of the new issue of BIOTECH Insight, the newsletter of Deutsche Börse AG.
Fresh money for Carbios
Latest NewsCarbios SAS has announced a capital increase of around €122m that may grow up to €141m.
Closed Loop Medicine appoints new COO
AppointmentsThe appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Company’s product and partnership programs.